Zai Lab Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Zai Lab Ltd - ADR
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
/ 
Frequently asked questions
To buy Zai Lab Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Zai Lab Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Zai Lab Ltd - ADR is ZLAB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Zai Lab Ltd - ADR has its primary listing on NASDAQ. You can trade Zai Lab Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Zai Lab Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Zai Lab Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Zai Lab Ltd - ADR.